Home
In development
PHLYXR is currently in preclinical testing and is not yet approved for STI prevention or contraception. We are designing it to be used alongside safer sex choices whilst we plan our clinical trials.
STIs remain high and drug resistance is rising
STI diagnoses remain high across England, and antibiotic resistance is a growing threat, particularly for gonorrhoea where treatment options are narrowing.
What we are building
PHLYXR is a next generation lubricant concept designed to combine a premium feel with an added protective function.
Texture and sensation matter. We are designing PHLYXR to be enjoyable to use, not a compromise.
pH aligned to the typical vaginal range and avoiding common irritants, so it is gentler on vaginal comfort.
Our formulation approach aims to bind and neutralise pathogens whilst acting as a spermicidal too. This is being tested in vitro.
How it works
No new behaviour, no interruption.
Designed to stay in place during sex.
Lab testing is focused on pathogen binding and viability reduction.
Progress
- ✅ MVP created and initial formulation work completed
- ✅ Characterisation work completed (rheology and stability checks)
- 🔄 In vitro testing and formulation refinement ongoing
- 📅 Next: patent filing, manufacturing scale up, and clinical planning
- 🎯 Target launch: 2027 (subject to trials and MHRA pathway)
For investors
Snapshot
- Stage: Preclinical in vitro testing
- Primary wedge: Premium lubricant with added prevention functionality
- Planned pathway: MHRA aligned clinical evaluation and regulatory strategy
- Raising: £1.8M (to fund safety work, clinical feasibility, and regulatory preparation)
Use of funds
- Preclinical efficacy and safety packages
- CRO supported safety data
- Early feasibility clinical trial
- Regulatory submission preparation and quality systems
Contact
- Investor enquiries: hello@phlyxr.com
- Startbook: View on Startbook
Team
Join the mailing list
Be first to hear about development updates, opportunities to test, and launch announcements.
What you get
- Early access and updates
- Opportunities to give feedback
- Launch announcements and offers
Take the survey
Your feedback shapes the product. It takes about 5 minutes.